Showing results (251-260 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Prostate Cancer and Prostatic Diseases|July 7, 2005
Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled studyO L Ozdal, C Ozden, K Benli, et al.
Prostate Cancer and Prostatic Diseases|July 7, 2005
Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancerY Miyoshi, H Uemura, H Ishiguro, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2007
A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsyA Takenaka, R Hara, T Ishimura, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2007
The influence of alpha1-antagonist on the expression pattern of TNF receptor family in primary culture of prostate epithelial cells from BPH patientsT Drewa, Z Wolski, B Misterek, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2023
Usefulness of podcasts to provide public education on prostate cancer geneticsStacy Loeb, Tatiana Sanchez Nolasco, Katherine Siu, et al.
Prostate Cancer and Prostatic Diseases|November 29, 2022
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancerJin-Soo Kim, Dennis R Taaffe, Daniel A Galvão, et al.
Prostate Cancer and Prostatic Diseases|December 2, 2022
The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohortMariaconsiglia Ferriero, Francesco Prata, Riccardo Mastroianni, et al.
Prostate Cancer and Prostatic Diseases|December 12, 2022
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysisTamás Fazekas, Ádám D Széles, Brigitta Teutsch, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2022
Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world settingStephen J Freedland, Agnes Hong, Nader El-Chaar, et al.
Pageof 199